British Journal of Cancer · 2015 · 180 citations · 23 references
MedicineImmunologyOncologyInflammationMetastasisTumor ProgressionCancer Cell SignalingEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionImmune Evasion In CancerInflammatory SignalingTumor ImmunopathologyBreast Cancer ProgressionCancer Cell ApoptosisEpithelial-mesenchymal Transition In CancerHepatocellular Carcinoma MetastasisInflammation-associated EmtInflammation-driven Tumor ProgressionLung AdenocarcinomaMixed Lymphocyte Reaction
BACKGROUND: Epithelial-to-mesenchymal transition (EMT) has a central role in cancer progression and metastatic dissemination and may be induced by local inflammation. We asked whether the inflammation-induced acquisition of mesenchymal phenotype by neoplastic epithelial cells is associated with the onset of mesenchymal stromal cell-like immune-regulatory properties that may enhance tumour immune escape. METHODS: Cell lines of lung adenocarcinoma (A549), breast cancer (MCF7) and hepatocellular carcinoma (HepG2) were co-cultured with T, B and NK cells before and after EMT induction by either the supernatant of mixed-lymphocyte reactions or inflammatory cytokines. RESULTS: EMT occurrence following inflammatory priming elicited multiple immune-regulatory effects in cancer cells resulting in NK and T-cell apoptosis, inhibition of lymphocyte proliferation and stimulation of regulatory T and B cells. Indoleamine 2,3-dioxygenase, but not Fas ligand pathway, was involved at least in part in these effects, as shown by the use of specific inhibitors. CONCLUSIONS: EMT induced by inflammatory stimuli confers to cancer cells some mesenchymal stromal cell-like immune-modulatory properties, which could be a cue for cancer progression and metastatic dissemination by favouring immune escape.
23
A Cell Culture Model for T Lymphocyte Clonal Anergy
Ronald H. Schwartz · Science · 1990 · 1.9K citations
Francesca Fallarino, Ursula Grohmann, Sylvaine You et al. · The Journal of Immunology · 2006 · 1K citations · Full text